Terms: = Uterine cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Diagnosis
4 results:
1. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the foxo1 signaling.
Zhang X; Xu Q; Li E; Shi T; Chen H
Mol Cell Biochem; 2023 Jul; 478(7):1561-1571. PubMed ID: 36434144
[TBL] [Abstract] [Full Text] [Related]
2. PI3K Pathway Effectors pAKT and foxo1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
[TBL] [Abstract] [Full Text] [Related]
3. Downregulation of foxo1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
[TBL] [Abstract] [Full Text] [Related]
4. Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by fkhr break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues.
Rivasi F; Botticelli L; Bettelli SR; Masellis G
Int J Gynecol Pathol; 2008 Jul; 27(3):442-6. PubMed ID: 18580325
[TBL] [Abstract] [Full Text] [Related]
